Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis

Multiple Sclerosis

Volumn 15, Issue 5, 2009, Pages 593-600

  Zéphir, Hélène ^a,b   Lefranc, D ^b   Dubucquoi, S ^b   de Seze, J ^c   Boron, L ^b   Prin, L ^b   Vermersch, P ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

B cells; Biomarker; CIS; IgG; Immunology; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PREDICTION;

ANTIBODY SPECIFICITY; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BRAIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 65349189954     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508101951     Document Type: Article

References (31)

1. Brex PA, O'Riordan JL, Miszkiel KA. Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology 1999; 53: 1184-1190.
2. Brex PA, Cicarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158-164.
3. Tintore M, Rovira A, Rio J. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006; 67: 968-972.
4. Masjuan J, Alvarez-Cermeno JC, Garcia-Barragan N. Clinically isolated syndromes. A new oligoclonal band test accurately predicts conversion to MS. Neurology 2006; 66: 576-578.
5. Kabat EA, Freedman DA, Murray JP. A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases. Am J Med Sci 1950; 219: 55-64.
6. Owens GP, Bennet JL, Gilden DH, Burgoon MP. The B cell response in multiple sclerosis. Neurol Res 2006; 28: 236-244.
7. Archelos JJ, Storch MK, Hartung HP. The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol 2000; 47: 696-706.
8. Cross AH, Trotter JL, Lyons J. B cells and antibodies in CNS demyelinating disease. J Neuorimmunol 2001; 112: 1-14.
9. Freedman MS, Thompson EJ, Deisenhammer F. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: A consensus statement. N Engl J Med 2005; 62: 865-870.
10. Falip M, Tintoré M, Jardi R, Duran I, Link H, Montalban X. Clinical usefulness of oligoclonal bands. Rev Neurol 2001; 32: 1120-1124.
11. Rauer S, Euler B, Reindl M, Berger T. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event. J Neurol Neurosurg Psychiatry 2006; 77: 739-742.
12. Egg R, Reindl M, Deisenhammer F. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Mult Scler 2001; 7: 285-289.
13. Lampasona V, Franciotta D, Furlan R. Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology 2004; 62: 2092-2094.
14. Mantegazza R, Cristaldini P, Bernasconi P. Anti-MOG autoantibodies in Italian multiple sclerosis patients: Specificity, sensitivity and clinical association. Int Immunol 2004; 16: 559-565.
15. Lefranc D, Almeras L, Dubucquoi S, de Seze J, Vermersch P, Prin L. Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool. J Immunol 2004; 172: 669-678.
16. Lefranc D, Launay D, Dubucquoi S. Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum 2007; 56: 3420-3432.
17. Zéphir H, Almeras L, El Behi M. Diversified serum IgG response involving non-myelin CNS proteins during experimental autoimmune encephalomyelitis. J Neuroimmunol 2006; 179: 53-64.
18. El Behi M, Zephir H, Lefranc D. Changes in self-reactive IgG antibody repertoire after treatment of experimental autoimmune encephalomyelitis with anti-allergic drugs. J Neuroimmunol 2007; 182: 80-88.
19. McDonald WI, Compston A, Edan G. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
20. Barkhof F, Filippi M, Miller DH. Comparison of MRI criteria at a first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
22. Zimmermann CW, Grus FH, Dux R. Multivariate statistical comparison of autoantibody-repertoires (Western blots) by discriminant analysis. Electrophoresis 1995; 16: 941-947.
23. Hawa M, Beyan H, Leslie RD. Principles of autoantibodies as disease-specific markers. Autoimmunity 2004; 37: 253-256.
24. Schwartz M, Cohen IR. Autoimmunity can benefit self-maintenance. Immunol Today 2000; 21: 265-268.
25. Lionel A, de Seze J, Didier L. Evolution of self-reactive IgG antibody repertoires in patients with relapsing-remitting multiple sclerosis. Immunol Lett 2005; 97: 55-62.
26. Hurez V, Dietrich G, Kaveri SV, Kazatchkine MD. Polyreactivity is a property of natural and disease-associated human autoantibodies. Scand J Immunol 1993; 38: 190-196.
27. Ronda N, Haury M, Nobrega A, Kaven SV, Coutinho A, Kazatchkine MD. Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell-IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int Immunol 1994; 6: 1651-1660.
28. Mouthon L, Haury M, Lacroix-Desmazes S, Barreau C, Coutinho A, Kazatchkine MD. Analysis of the normal human IgG antibody repertoire. Evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. J Immunol 1995; 154: 5769-5778.
29. Lacroix-Desmazes S, Mouthon L, Coutinho A, Kazatchkine D. Analysis of the natural human IgG antibody repertoire: Life-long stability of reactivities towards self-antigens contrasts with age-dependent diversification of reactivities against bacterial antigens. Eur J Immunol 1995; 25: 2598-2604.
30. Stahl D, Lacroix-Desmazes S, Mouthon L, Kaveri SV, Kazatchkine MD. Analysis of human self-reactive antibody repertoires by quantitative immunoblotting. J Immunol Methods 2000; 240: 1-14.
31. Lacroix-Desmazes S, Resnick I, Stahl D. Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. J Immunol 1999; 162: 5601-5608.